Tonix Pharma's total assets for Q3 2025 were $252.44M, an increase of 34.74% from the previous quarter. TNXP total liabilities were $21.30M for the fiscal quarter, a 10.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.